HomeLIXT • NASDAQ
add
Lixte Biotechnology Holdings Inc
Previous close
$2.88
Day range
$2.84 - $2.94
Year range
$1.58 - $9.50
Market cap
6.53M USD
Avg Volume
1.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.03M | -37.16% |
Net income | -1.03M | 36.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.20M | -21.48% |
Total assets | 4.31M | -22.52% |
Total liabilities | 313.86K | -20.69% |
Total equity | 3.99M | — |
Shares outstanding | 2.25M | — |
Price to book | 13.09 | — |
Return on assets | -53.75% | — |
Return on capital | -57.52% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.03M | 36.72% |
Cash from operations | -902.12K | 25.35% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -902.12K | 25.35% |
Free cash flow | -517.40K | 13.74% |
About
Founded
2005
Website
Employees
3